In primary endometrial cancer lesions, PIK3CA is the second most frequently significant mutated gene after PTEN, with a frequency of 53% according to comprehensive genomic profiling including whole exome sequencing performed by The Cancer Genome Atlas (TCGA)5, 13, 14. This evidence concerns the gene PIK3CA and endometrial cancer.